Anti-leishmanial activity of neolignans from Virola species and synthetic analogues

Phytochemistry

Volumn 55, Issue 6, 2000, Pages 589-595

  Barata, Lauro E S ^a   Santos, Lourivaldo S ^b   Ferri, Pedro H ^c   Phillipson, J David ^d   Paine, Angela ^e   Croft, Simon L ^e  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^c FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^d UNIVERSITY OF LONDON   (United Kingdom)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Ketoamines; Ketoethers; Ketosulfides; Anti leishman ial activity; Leishmania donovani; Myristicaceae; Neolignans; Virola pavonis; Virola surinamensis

Indexed keywords

(3,4 DIMETHOXY) 8 (4' METHYLTHIOPHENOXY)PROPIOPHENONE; 3,4,5 TRIMETHOXY 8 (2',6' DIMETHOXY 4' PROPENYLPHENOXY)PHENYLPROPANE; ANISOLE DERIVATIVE; ANTIPROTOZOAL AGENT; LIGNAN; NEOLIGNAN; SURINAMENSIN; UNCLASSIFIED DRUG;

AMASTIGOTE; ANGIOSPERM; ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DRUG ISOLATION; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LEISHMANIA DONOVANI; LEISHMANIASIS; MOUSE; MOUSE STRAIN; NONHUMAN; PLANT; PROMASTIGOTE; SURINAMENSIN; VIROLA; VISCERAL LEISHMANIASIS;

ANGIOSPERMS; ANIMALS; ANISOLES; ANTIPROTOZOAL AGENTS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; FEMALE; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LIGNANS; MICE; MICE, INBRED BALB C;

ANIMALIA; LEISHMANIA DONOVANI; MAGNOLIOPHYTA; MYRISTICACEAE; VIROLA; VIROLA SURINAMENSIS;

EID: 0034736133     PISSN: 00319422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9422(00)00240-5     Document Type: Article

References (25)

1. Antileishmanial activity of compounds extracted and characterized from Centrolobium sclerophyllum
2. Recent advances in the fight against leishmaniasis with natural products
3. Estimation of population at risk of infection and number of cases of leishmaniasis
4. Natural and synthetic bioactive neolignans
5. Neolignans of Virola surinamensis
6. Human leishmaniasis: Clinical, diagnostic and chemotherapeutic developments in the last 10 years
7. Antileishmanial activity of licochalcone A in mice infected with Leishmania major and in hamsters infected with Leishmania donovani
8. SAR analysis of synthetic neolignans and related compounds which are antileishmaniasis active compounds using pattern recognition methods
9. Conformation of Neolignans that binds to the arginine residue in adenosine kinase from Leishmania donovani
10. Neolignans and a new phenylpropanoid from Virola pavonis leaves
11. In vivo oral and intralesional administration of 2-substituted quinolines in experimental treatment of new world cutaneous leishmaniasis caused by Leishmania amazonensis
12. Neolignans
13. Medicinal plants in the fight against leishmaniasis
14. The crystal structure of 1-(3',4'-dimethoxyphenyl)-1-propanone, a Platelet Activating Factor (PAF-acether) antagonist
15. Atividade antimicrobiana de neolignanas 8.O.4' e derivados sinteticos-1
16. Biological activities of lignans
17. An in vitro system for determining the activity of compounds against the intracellular amastigote form of L. donovani
18. Acao da neolignana virolina e derivados em leucemia experimental
19. Practical progress and new drugs for changing patterns of leishmaniasis
20. Determination of absolute configuration of (+)- surinamensin via diastereomeric o-methyl mandelic esters
21. New synthetic route to 8.O.4' neolignans using abundant Brazilian natural products
22. The selective effect of 2',6'-dihydroxy-4'-methoxychalcone isolated from Piper aduncum on Leishmania amazonensis
23. Improvement of in vitro and in vivo antileishmanial activity of 2', 6'-dihydroxy-4'-methoxychalcone by encapsulation in poly (D, L-lactide) nanoparticles
24. Medicinal plants against protozoal diseases